GB201715122D0 - Topical anti-infective formulation - Google Patents
Topical anti-infective formulationInfo
- Publication number
- GB201715122D0 GB201715122D0 GBGB1715122.6A GB201715122A GB201715122D0 GB 201715122 D0 GB201715122 D0 GB 201715122D0 GB 201715122 A GB201715122 A GB 201715122A GB 201715122 D0 GB201715122 D0 GB 201715122D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- topical anti
- infective formulation
- infective
- formulation
- topical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1715122.6A GB201715122D0 (en) | 2017-09-19 | 2017-09-19 | Topical anti-infective formulation |
| PCT/IB2018/057203 WO2019058268A1 (en) | 2017-09-19 | 2018-09-19 | Topical anti-infective formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1715122.6A GB201715122D0 (en) | 2017-09-19 | 2017-09-19 | Topical anti-infective formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201715122D0 true GB201715122D0 (en) | 2017-11-01 |
Family
ID=60159303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1715122.6A Ceased GB201715122D0 (en) | 2017-09-19 | 2017-09-19 | Topical anti-infective formulation |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201715122D0 (en) |
| WO (1) | WO2019058268A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11318149B2 (en) * | 2018-09-27 | 2022-05-03 | Board Of Trustees Of Michigan State University | Compositions and methods for inhibiting biofilm-forming bacteria |
| CN111214449B (en) * | 2020-03-02 | 2021-09-07 | 广东彼迪药业有限公司 | A kind of cetirizine hydrochloride tablet and preparation method thereof |
| JP2024546893A (en) * | 2021-12-17 | 2024-12-26 | ビーエーエスエフ ソシエタス・ヨーロピア | Compositions Comprising Antimicrobial Agents and Carboxamides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI260220B (en) * | 1999-11-22 | 2006-08-21 | Novartis Ag | A pharmaceutical composition for the transdermal treatment of bacterial infections in animals |
| GB0316377D0 (en) * | 2003-07-12 | 2003-08-13 | Norbrook Lab Ltd | Parasiticidal composition |
| US7576054B2 (en) * | 2005-10-11 | 2009-08-18 | Biosynexus Incorporated | Compositions and methods for treating bacteria |
| WO2012023082A1 (en) * | 2010-08-17 | 2012-02-23 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - terbinafine hydrochloride, and a process to make it |
| FR2991173B1 (en) * | 2012-06-04 | 2015-11-06 | Virbac | VETERINARY COMPOSITION WITH OXYCLOZANIDE BASED SKIN ADMINISTRATION |
-
2017
- 2017-09-19 GB GBGB1715122.6A patent/GB201715122D0/en not_active Ceased
-
2018
- 2018-09-19 WO PCT/IB2018/057203 patent/WO2019058268A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019058268A1 (en) | 2019-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202007965B (en) | Topical pharmaceutical compositions | |
| SG11201701292XA (en) | Topical formulation | |
| ZA201800080B (en) | Topical retinoid compositions | |
| GB201604484D0 (en) | Topical antibacterial compositions | |
| IL274139A (en) | Aerosolisable formulation | |
| GB201709918D0 (en) | Topical formulation | |
| SG11202000615VA (en) | Topical composition | |
| IL274719A (en) | Formulation | |
| GB201514758D0 (en) | Formulation | |
| GB201713724D0 (en) | Formulation | |
| PT3173071T (en) | Maropitant formulation | |
| GB201502845D0 (en) | Topical pharmaceutical formulation | |
| IL272944A (en) | Topical compositions | |
| IL268374A (en) | Topical composition | |
| GB201715122D0 (en) | Topical anti-infective formulation | |
| GB201706969D0 (en) | Formulation | |
| GB201719464D0 (en) | Formulation | |
| GB201713160D0 (en) | Topical composition | |
| ZA201605935B (en) | Topical antibiotic formulations | |
| GB201521771D0 (en) | Formulation | |
| GB201511255D0 (en) | Formulation | |
| GB201509891D0 (en) | Formulation | |
| GB201609968D0 (en) | Topical pharmaceutical formulation | |
| EP3322482C0 (en) | Topical ciprofloxacin compositions | |
| GB201513108D0 (en) | Topical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |